GeoVax Receives Patent for VLP Ebola Vaccine
GeoVax Labs, Inc. today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for Patent ...
GeoVax Labs, Inc. today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for Patent ...
Lassa fever causes multisystem disease and has a fatality rate <70%. Severe cases exhibit abnormal coagulation, endothelial barrier disruption, and ...
Lassa virus (LASV) has been added to the WHO R&D Blueprint list of diseases for which there is an urgent ...
The Nigerian Academy of Science has called for the current outbreak of Lassa fever in Africa’s most populous nation to ...
The U.S. Centers for Disease Control and Prevention (CDC) updates an existing Level 1 Travel Alert for Monkeypox in the ...
Inovio Pharmaceuticals, Inc. today announced the Coalition for Epidemic Preparedness Innovations (CEPI) has awarded Inovio a grant of up to ...
Three British nationals have been brought back to the UK from Sierra Leone for medical assessment after coming into close contact with ...
60 percent of new infectious diseases that emerge in people—including HIV, Ebola , and Nipah, all of which originated in ...
The U.S. Centers for Disease Control and Prevention has issued a funding opportunity in support of improved vector surveillance and ...
The Naval Research Laboratory (NRL) is seeking partners to advance technology developed for in vitro diagnostic devices that are amenable ...
The Defense Threat Reduction Agency (DTRA) seeks to identify, adopt, and adapt emerging, existing and revolutionary sciences that may demonstrate ...
Profectus BioSciences, Inc. has received a contract for up to $22.25 million from the National Institute of Allergy and Infectious ...
A global coalition to create new vaccines for emerging infectious diseases, designed to help give the world an insurance policy ...
Credit: Shutterstock Zalgen Labs recently announced that it has entered into a series of agreements with NOWDiagnostics (NOWDx) to collaborate ...
The World Health Organization today provided an update on the two cases of Lassa fever reported from German health authorities. ...
The National Institute of Allergy and Infectious Diseases (NIAID) is seeking proposals for advanced development of multivalent vaccines against Ebola ...
The Ebola virus acts fast. The course of infection, from exposure to recovery, or death, can take as little as ...
The National Institute of Allergy and Infectious Diseases (NIAID) is seeking information from pharmaceutical and biopharmaceutical product developers on multivalent ...
A man died of Lassa fever at a hospital in New Jersey on Monday after returning from Liberia this month, ...
The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) is soliciting development and deployment of MAGPIX-based immunoassays which will ...